May 4, 2010
SANTA MONICA, Calif., May 4 /PRNewswire-FirstCall/ -- Derycz Scientific, Inc. (OTC Bulletin Board: DYSC), the content repurposing company, today announced that its subsidiary Reprints Desk, an award-winning provider of information services and content workflow solutions, has launched ePrints NRx, a new scientific article collection service that simplifies the re-use of PDFs by medical marketers, brand managers and sales professionals. The service, recently deployed for multiple Reprints Desk customers, provides these professionals with a copyright-compliant "plug and play" type of licensing solution for using multiple articles from multiple content sources in online portals, physician detailing and edetailing, and digital marketing initiatives.
ePrints NRx was conceived after recent collaboration among Reprints Desk, leading scientific, technical, and medical (STM) publishers and two of the world's top-10 pharmaceutical companies. The collaboration led to the deployment of ePrints within a leading closed-loop marketing (CLM) solution and an online portal for healthcare consumers. The service is designed to solve common and persistent challenges that have stalled the long-predicted surge in article ePrint usage in the pharmaceutical, biotechnology and medical device industries:
Peter Derycz, President and Chief Executive Officer of Derycz Scientific, said: "ePrints NRx is a breakthrough for every medical marketer and brand management professional who has wanted to incorporate a group of scientific article ePrints into their program or campaign, only to run into various licensing, technical and budgeting challenges."
ePrints NRx service components include publisher relationship management and collaboration, annual or transactional licensing, workflow and technical requirements determinations, electronic content delivery or hosting for on-demand PDF downloads, reporting, and integration with third-party sales and marketing software services.
For more information, visit www.reprintsdesk.com.
About Derycz Scientific®
Derycz Scientific, Inc. (the "Company") develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk and Pools Press. Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprint Desk is an innovator in content retrieval and ePrint delivery and its services are designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for over 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces, newsletters, and all business stationery; and works with publishers who wish to outsource a portion of or all of their reprints business. For more information, go to www.deryczscientific.com.
About Reprints Desk®
Reprints Desk, Inc., is a business software and information services company that simplifies how research-intensive companies and other organizations procure, manage and share journal articles and other copyright-protected content. The company's content workflow and compliance solutions help customers effectively use peer-reviewed literature in research, regulatory submissions, and product promotions. A channel supplier for more than 100 scientific, technical, and medical (STM) publishers, Reprints Desk earned the #1 ranking in the 2008 Document Delivery Vendor Scorecard by Outsell, Inc., and currently serves companies in life sciences, energy, aerospace, industrial products, food and beverages, consumer packaged goods, information technology, legal, academia, and government. Reprints Desk is a Derycz Scientific company. For more information about Reprints Desk, go to www.reprintsdesk.com.
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. The Company assumes no obligation to update the information in this release.
SOURCE Derycz Scientific, Inc.